Test Singapore Translational Cancer Consortium (STCC)  joint platform  enable  collaboration  between basic, clinical and translational researchers  to  explore novel  approaches,  push  promising  lines  of  research and translation, and seed ideas for larger competitive translational grants. We are now in Phase 1 implementation, focusing on the operationalization of the four joint platforms:   

STCC Cancer Clinical Trials and Investigational Medicine Units platform brings together several excellent clinical trial centres in Singapore for scaled up expertise, capacity and efficiency in conducting cancer clinical trials. This platform will work closely with the other STCC entities to conduct biomedical research of the highest quality, as well as enhance partnerships by engaging […]

The Cancer Database and Tissue Banks Platform combines existing databases of the Singhealth and National University Health System Tissue Repositories (NUHS TR) and is aligned with the Singapore Network of Biorepositories (SINB), which catalogues specimens and data of other disease types. This will serve as a common national-level resource platform that supports investigators’ queries by […]

The Translational Research Integration & Support (TRIS) offers potential solutions to several healthcare challenges in oncology by improving patient stratification for standard and novel therapies. It is a national-level platform to bring together expertise from the Agency of Science, Technology and Research (A*STAR), and academic cancer researchers in Singapore, with the common goal of developing, […]

The Business Intelligence and Development Unit serves as STCC’s dedicated business team for active industry engagements. This platform develops outreach strategies, and provides a single contact point to all industry partners interested in cancer-related clinical and research collaborations. The BID Platform strives to provide a business intelligence perspective to guide STCC’s research outcomes towards industry […]